{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:47:45Z","timestamp":1740134865963,"version":"3.37.3"},"reference-count":10,"publisher":"American Society of Hematology","issue":"15","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2019,10,10]]},"DOI":"10.1182\/blood.2019002420","type":"journal-article","created":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T03:28:27Z","timestamp":1570678107000},"page":"1200-1201","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":2,"title":["PET-adapted treatment of Hodgkin lymphoma"],"prefix":"10.1182","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3873-1741","authenticated-orcid":false,"given":"Martin","family":"Hutchings","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2019,8,13]]},"reference":[{"issue":"15","key":"2019111523034515900_B1","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1182\/blood.2019000719","article-title":"Five-year follow-up of SWOG S0816: limitations and values of a PET-adapted approach with stage III\/IV Hodgkin lymphoma","volume":"134","author":"Stephens","year":"2019","journal-title":"Blood"},{"issue":"4","key":"2019111523034515900_B2","first-page":"482","article-title":"Position emission tomography with or without computed tomography in the primary staging of Hodgkin\u2019s lymphoma","volume":"91","author":"Hutchings","year":"2006","journal-title":"Haematologica"},{"issue":"25","key":"2019111523034515900_B3","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1056\/NEJMoa1510093","article-title":"Adapted treatment guided by interim PET-CT scan in advanced Hodgkin\u2019s lymphoma","volume":"374","author":"Johnson","year":"2016","journal-title":"N Engl J Med"},{"issue":"5","key":"2019111523034515900_B4","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1200\/JCO.2017.75.2543","article-title":"Early chemotherapy intensification with escalated BEACOPP in patients with advanced-stage Hodgkin lymphoma with a positive interim positron emission tomography\/computed tomography scan after two ABVD cycles: long-term results of the GITIL\/FIL HD 0607 Trial","volume":"36","author":"Gallamini","year":"2018","journal-title":"J Clin Oncol"},{"issue":"10114","key":"2019111523034515900_B5","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1016\/S0140-6736(17)32134-7","article-title":"PET-guided treatment in patients with advanced-stage Hodgkin\u2019s lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group","volume":"390","author":"Borchmann","year":"2018","journal-title":"Lancet"},{"issue":"4","key":"2019111523034515900_B6","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1056\/NEJMoa1708984","article-title":"Brentuximab vedotin with chemotherapy for stage III or IV Hodgkin\u2019s lymphoma","volume":"378","author":"Connors","year":"2018","journal-title":"N Engl J Med"},{"key":"2019111523034515900_B7","doi-asserted-by":"crossref","unstructured":"Straus\n              DJ\n            , D\u0142ugosz-DaneckaM, AlekseevS, \n          Brentuximab vedotin with chemotherapy for stage 3\/4 classical Hodgkin lymphoma: Three-year update of the ECHELON-1 study. Presented at the 2019 American Society of Clinical Oncology Annual Meeting. 3 June 2019. Chicago, IL.","DOI":"10.1097\/01.HS9.0000561560.35825.0d"},{"issue":"22","key":"2019111523034515900_B8","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1182\/blood-2017-11-812073","article-title":"Circulating tumor DNA reveals genetics, clonal evolution, and residual disease in classical Hodgkin lymphoma","volume":"131","author":"Spina","year":"2018","journal-title":"Blood"},{"issue":"5","key":"2019111523034515900_B9","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/bjh.14317","article-title":"Biomarkers for evaluation of treatment response in classical Hodgkin lymphoma: comparison of sGalectin-1, sCD163 and sCD30 with TARC","volume":"175","author":"Plattel","year":"2016","journal-title":"Br J Haematol"},{"key":"2019111523034515900_B10","unstructured":"ClinicalTrials.gov\n          . Very early PET-response adapted targeted therapy for advanced Hodgkin lymphoma: a single-arm phase II study (COBRA). Identifier: NCT03517137. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03517137?term=Hutchings&cond=Hodgkin&rank=1. Accessed 26 August 2019."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/134\/15\/1200\/1223414\/bloodbld2019002420c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/134\/15\/1200\/1223414\/bloodbld2019002420c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,16]],"date-time":"2019-11-16T00:19:15Z","timestamp":1573863555000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/134\/15\/1200\/374444\/PETadapted-treatment-of-Hodgkin-lymphoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,13]]},"references-count":10,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2019,8,13]]},"published-print":{"date-parts":[[2019,10,10]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2019002420","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"type":"print","value":"0006-4971"},{"type":"electronic","value":"1528-0020"}],"subject":[],"published":{"date-parts":[[2019,8,13]]}}}